Ketil Dahl

1.0k total citations
21 papers, 755 citations indexed

About

Ketil Dahl is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Transplantation. According to data from OpenAlex, Ketil Dahl has authored 21 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pharmacology and 4 papers in Transplantation. Recurrent topics in Ketil Dahl's work include Renal Transplantation Outcomes and Treatments (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Cardiovascular Health and Disease Prevention (4 papers). Ketil Dahl is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Cardiovascular Health and Disease Prevention (4 papers). Ketil Dahl collaborates with scholars based in Norway, Sweden and Denmark. Ketil Dahl's co-authors include Svend Aakhus, Tor‐Erik Widerøe, Friedo W. Dekker, Cecilia Montgomery Øien, Stein Hallan, Jostein Holmen, Diana C. Grootendorst, L. C. Smeby, K. J. Berg and Pascal Pfister and has published in prestigious journals such as Journal of the American College of Cardiology, BMJ and The American Journal of Cardiology.

In The Last Decade

Ketil Dahl

21 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ketil Dahl Norway 10 316 220 216 169 127 21 755
Şehsuvar Ertürk Türkiye 16 524 1.7× 114 0.5× 284 1.3× 236 1.4× 119 0.9× 61 1.1k
Maxence Ficheux France 14 470 1.5× 301 1.4× 203 0.9× 45 0.3× 72 0.6× 62 955
Murray L. Levin United States 13 214 0.7× 63 0.3× 159 0.7× 97 0.6× 111 0.9× 28 630
Wisit Kaewput Thailand 18 275 0.9× 100 0.5× 255 1.2× 159 0.9× 104 0.8× 90 985
Liviu Segall Romania 15 423 1.3× 75 0.3× 182 0.8× 154 0.9× 83 0.7× 25 828
Amy C. Wilson United States 17 298 0.9× 93 0.4× 138 0.6× 146 0.9× 178 1.4× 38 827
Jeffrey Mulhern United States 13 454 1.4× 101 0.5× 158 0.7× 49 0.3× 112 0.9× 27 691
Johannes M. M. Boots Netherlands 17 125 0.4× 774 3.5× 439 2.0× 79 0.5× 86 0.7× 27 1.2k
Ahmed Hamdy Egypt 10 69 0.2× 177 0.8× 265 1.2× 49 0.3× 46 0.4× 24 628
Grant Luxton Australia 13 835 2.6× 148 0.7× 159 0.7× 43 0.3× 215 1.7× 23 1.2k

Countries citing papers authored by Ketil Dahl

Since Specialization
Citations

This map shows the geographic impact of Ketil Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ketil Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ketil Dahl more than expected).

Fields of papers citing papers by Ketil Dahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ketil Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ketil Dahl. The network helps show where Ketil Dahl may publish in the future.

Co-authorship network of co-authors of Ketil Dahl

This figure shows the co-authorship network connecting the top 25 collaborators of Ketil Dahl. A scholar is included among the top collaborators of Ketil Dahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ketil Dahl. Ketil Dahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Getz, Linn, et al.. (2010). Blodtrykksapparater på legekontorer. Tidsskrift for Den norske legeforening. 130(12). 1233–1235. 1 indexed citations
2.
Wisløff, Ulrik, et al.. (2008). Left ventricular apical rotation is related to ambulatory blood pressure and body mass in healthy elderly females. Blood Pressure. 17(3). 147–155. 1 indexed citations
3.
Hallan, Stein, Ketil Dahl, Cecilia Montgomery Øien, et al.. (2006). Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 333(7577). 1047–1047. 250 indexed citations
5.
Aakhus, Svend, et al.. (2004). Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5‐yr follow‐up. Clinical Transplantation. 18(5). 596–604. 85 indexed citations
6.
Aakhus, Svend, et al.. (1999). Total Arterial Compliance in Ambulatory Hypertension During Selective β1-Adrenergic Receptor Blockade and Angiotensin-Converting Enzyme Inhibition. Journal of Cardiovascular Pharmacology. 33(2). 273–279. 7 indexed citations
7.
Aakhus, Svend, Ketil Dahl, & Tor‐Erik Widerøe. (1999). Cardiovascular morbidity and risk factors in renal transplant patients. Nephrology Dialysis Transplantation. 14(3). 648–654. 172 indexed citations
8.
Dahl, Ketil, et al.. (1996). Left ventricular systolic and diastolic function assessed with two-dimensional and Doppler echocardiography in “white coat” hypertension. Journal of the American College of Cardiology. 28(1). 190–196. 21 indexed citations
9.
Aakhus, S., et al.. (1996). Hemodynamics in White Coat Hypertension Compared to Ambulatory Hypertension and Normotension*. American Journal of Hypertension. 9(11). 1090–1098. 20 indexed citations
10.
Aakhus, Svend, et al.. (1996). Hyperlipidaemia in renal transplant patients. Journal of Internal Medicine. 239(5). 407–415. 55 indexed citations
11.
Dahl, Ketil, et al.. (1996). Pharmacokinetics of Transperitoneal Insulin Transport. Nephron. 74(2). 283–290. 3 indexed citations
12.
Holdaas, Hallvard, et al.. (1995). Effect of fluvastatin for safely loweringatherogenic lipids in renal transplant patients receiving cyclosporine. The American Journal of Cardiology. 76(1-2). 102A–106A. 42 indexed citations
13.
Kulzer, Peter, R. M. Schaefer, Liliana Schaefer, et al.. (1994). Effectiveness and Safety of Recombinant Human Erythropoietin (r-HuEPO) in the Treatment of Anemia of Chronic Renal Failure in Non Dialysis Patients. The International Journal of Artificial Organs. 17(4). 195–202. 7 indexed citations
14.
Edwall, Björn, et al.. (1994). Pharmacokinetics of oral cefcanel daloxate hydrochloride in healthy volunteers and patients with various degrees of impaired renal function. Journal of Antimicrobial Chemotherapy. 33(2). 281–288. 1 indexed citations
15.
Dahl, Ketil, R. A. Walstad, & Tor‐Erik Widerøe. (1990). The Effect of Peritonitis on the Transperitoneal Transport of Cefuroxime in Patients on CAPD Treatment. Nephrology Dialysis Transplantation. 5(4). 275–281. 4 indexed citations
16.
Widerøe, Tor‐Erik, L. C. Smeby, Ketil Dahl, & Størker Jørstad. (1988). Definitions of Differences and Changes in Peritoneal Membrane Water Transport Properties. Artificial Organs. 12(3). 210–218. 6 indexed citations
17.
Walstad, R. A., et al.. (1988). The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy. European Journal of Clinical Pharmacology. 35(3). 273–279. 7 indexed citations
18.
Dahl, Ketil, et al.. (1988). Definitions of differences and changes in peritoneal membrane transport properties.. PubMed. 24. S107–13. 9 indexed citations
19.
Rygnestad, Tarjei, R. A. Walstad, & Ketil Dahl. (1986). Self‐poisoning with Theophylline. Acta Medica Scandinavica. 219(4). 425–427. 11 indexed citations
20.
Widerøe, Tor‐Erik, et al.. (1984). Long-Term Changes in Transperitoneal Water Transport during Continuous Ambulatory Peritoneal Dialysis. ˜The œNephron journals/Nephron journals. 38(4). 238–247. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026